A new analysis from Deloitte indicates that healthcare organizations are increasingly investing in agent-based artificial intelligence as technical and organizational barriers begin to ease. The study from the Deloitte Center

Become a Member

Members have access to all articles.

Membership
for Health Solutions shows that 85% of healthcare leaders expect to increase spending on agentic AI over the next two to three years, while 61% are already developing or implementing AI agents within their operations. 

These systems, designed to perform multi-step tasks autonomously, are being explored to improve administrative efficiency, clinical workflows, and operational decision-making. Researchers note that healthcare organizations are gradually moving beyond experimental pilots toward broader deployment, although success will depend on how effectively organizations redesign their operating models to support these technologies.

The report also highlights an emerging divide between early adopters and organizations taking a cautious approach. Deloitte researchers noted that health care leaders are increasingly embracing agentic AI as barriers to adoption begin to decline, while emphasizing that achieving meaningful returns will require scaling initiatives across enterprise systems rather than limiting them to isolated experiments. 

Leaders expect agentic AI to assist with complex tasks such as care coordination, administrative processing, and decision support, potentially improving productivity and patient experiences. However, the study stresses that technology deployment alone is insufficient; healthcare providers must address governance, workforce readiness, and data integration challenges to unlock long-term value. Overall, the research suggests that organizations able to integrate agentic AI into their operating structures could achieve efficiency gains and better clinical outcomes as the technology matures.

Read more